A carregar...
Lorazepam challenge for individuals at varying genetic risk for Alzheimer’s disease
INTRODUCTION: This study set out to clarify the differential acute cognitive impact of lorazepam based on varying genetic risk for Alzheimer’s disease. METHODS: Fifty-seven cognitively unimpaired individuals aged 51 to 88, genotyped according to apolipoprotein E (APOE) and translocase of outer mitoc...
Na minha lista:
| Publicado no: | Alzheimer Dis Assoc Disord |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5699956/ https://ncbi.nlm.nih.gov/pubmed/28582280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000200 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|